This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Jun 20;26(18):3100; author reply 3100-a-3101.

doi: 10.1200/JCO.2008.16.9326.

Nonmetastatic pancreatic cancer: many trials, little progress

Jörg Kleeff, Helmut Friess

PMID: 18565903
DOI: 10.1200/JCO.2008.16.9326

Comment

Nonmetastatic pancreatic cancer: many trials, little progress

Jörg Kleeff et al. J Clin Oncol. 2008.

. 2008 Jun 20;26(18):3100; author reply 3100-a-3101.

doi: 10.1200/JCO.2008.16.9326.

Authors

Jörg Kleeff, Helmut Friess

PMID: 18565903
DOI: 10.1200/JCO.2008.16.9326

No abstract available

PubMed Disclaimer

Comment on

Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
Small W Jr, Berlin J, Freedman GM, Lawrence T, Talamonti MS, Mulcahy MF, Chakravarthy AB, Konski AA, Zalupski MM, Philip PA, Kinsella TJ, Merchant NB, Hoffman JP, Benson AB, Nicol S, Xu RM, Gill JF, McGinn CJ. Small W Jr, et al. J Clin Oncol. 2008 Feb 20;26(6):942-7. doi: 10.1200/JCO.2007.13.9014. J Clin Oncol. 2008. PMID: 18281668 Clinical Trial.

Similar articles

[Results of gemcitabine hydrochloride in the treatment for pancreatic cancer].
Tsukagoshi S. Tsukagoshi S. Gan To Kagaku Ryoho. 2001 Oct;28(10):1461-7. Gan To Kagaku Ryoho. 2001. PMID: 11681259 Review. Japanese.
Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Shivnani AT. Shivnani AT. JAMA. 2007 Jun 20;297(23):2581-2; author reply 2582. doi: 10.1001/jama.297.23.2581-b. JAMA. 2007. PMID: 17579222 No abstract available.
Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma.
Brown ZJ, Cloyd JM. Brown ZJ, et al. J Surg Oncol. 2021 May;123(6):1432-1440. doi: 10.1002/jso.26384. J Surg Oncol. 2021. PMID: 33831253 Review.
[Chemoradiation for pancreatic adenocarcinoma].
Flandin I, Mornex F, Claude L, Kubas A, Khodri M, Wautot V, Mazeron R, Partensky C. Flandin I, et al. Cancer Radiother. 2004 Nov;8 Suppl 1:S80-7. Cancer Radiother. 2004. PMID: 15679252 Review. French.
Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.
Boeck S, Heinemann V. Boeck S, et al. J Clin Oncol. 2008 Mar 1;26(7):1178-9; author reply 1179. doi: 10.1200/JCO.2007.15.3304. J Clin Oncol. 2008. PMID: 18309957 No abstract available.

See all similar articles

Cited by

ALCAM (CD166) expression and serum levels in pancreatic cancer.
Tachezy M, Zander H, Marx AH, Stahl PR, Gebauer F, Izbicki JR, Bockhorn M. Tachezy M, et al. PLoS One. 2012;7(6):e39018. doi: 10.1371/journal.pone.0039018. Epub 2012 Jun 20. PLoS One. 2012. PMID: 22745698 Free PMC article.
High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.
Wang L, Gu F, Liu CY, Wang RJ, Li J, Xu JY. Wang L, et al. Tumour Biol. 2013 Apr;34(2):853-8. doi: 10.1007/s13277-012-0617-7. Epub 2012 Dec 16. Tumour Biol. 2013. PMID: 23242609
High expression of CX3CL1/CX3CR1 axis predicts a poor prognosis of pancreatic ductal adenocarcinoma.
Xu X, Wang Y, Chen J, Ma H, Shao Z, Chen H, Jin G. Xu X, et al. J Gastrointest Surg. 2012 Aug;16(8):1493-8. doi: 10.1007/s11605-012-1921-7. Epub 2012 May 26. J Gastrointest Surg. 2012. PMID: 22639377
Pancreatic cancer-improved care achievable.
Buanes TA. Buanes TA. World J Gastroenterol. 2014 Aug 14;20(30):10405-18. doi: 10.3748/wjg.v20.i30.10405. World J Gastroenterol. 2014. PMID: 25132756 Free PMC article. Review.
Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers.
Herrmann K, Walch A, Balluff B, Tänzer M, Höfler H, Krause BJ, Schwaiger M, Friess H, Schmid RM, Ebert MP. Herrmann K, et al. Nat Clin Pract Gastroenterol Hepatol. 2009 Mar;6(3):170-83. doi: 10.1038/ncpgasthep1366. Nat Clin Pract Gastroenterol Hepatol. 2009. PMID: 19259108 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information